Literature DB >> 33558477

IgSF11 regulates osteoclast differentiation through association with the scaffold protein PSD-95.

Hyunsoo Kim1, Noriko Takegahara1, Matthew C Walsh1, Sarah A Middleton2, Jiyeon Yu1, Jumpei Shirakawa1, Jun Ueda3, Yoshitaka Fujihara3, Masahito Ikawa3, Masaru Ishii4, Junhyong Kim2, Yongwon Choi5.   

Abstract

Osteoclasts are multinucleated, giant cells derived from myeloid progenitors. While receptor activator of NF-κB ligand (RANKL) stimulation is the primary driver of osteoclast differentiation, additional signaling further contributes to osteoclast maturation. Here, we demonstrate that immunoglobulin superfamily member 11 (IgSF11), whose expression increases during osteoclast differentiation, regulates osteoclast differentiation through interaction with postsynaptic density protein 95 (PSD-95), a scaffold protein with multiple protein interaction domains. IgSF11 deficiency in vivo results in impaired osteoclast differentiation and bone resorption but no observed defect in bone formation. Consequently, IgSF11-deficient mice exhibit increased bone mass. Using in vitro osteoclast culture systems, we show that IgSF11 functions through homophilic interactions. Additionally, we demonstrate that impaired osteoclast differentiation in IgSF11-deficient cells is rescued by full-length IgSF11 and that the IgSF11-PSD-95 interaction requires the 75 C-terminal amino acids of IgSF11. Our findings reveal a critical role for IgSF11 during osteoclast differentiation and suggest a role for IgSF11 in a receptor- and signal transduction molecule-containing protein complex.

Year:  2020        PMID: 33558477     DOI: 10.1038/s41413-019-0080-9

Source DB:  PubMed          Journal:  Bone Res        ISSN: 2095-4700            Impact factor:   13.567


  41 in total

Review 1.  Reaching a genetic and molecular understanding of skeletal development.

Authors:  Gerard Karsenty; Erwin F Wagner
Journal:  Dev Cell       Date:  2002-04       Impact factor: 12.270

Review 2.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

Review 3.  The genetic basis for skeletal diseases.

Authors:  Elazar Zelzer; Bjorn R Olsen
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

Review 4.  Genetic regulation of osteoclast development and function.

Authors:  Steven L Teitelbaum; F Patrick Ross
Journal:  Nat Rev Genet       Date:  2003-08       Impact factor: 53.242

Review 5.  Osteoimmunology: interplay between the immune system and bone metabolism.

Authors:  Matthew C Walsh; Nacksung Kim; Yuho Kadono; Jaerang Rho; Soo Young Lee; Joseph Lorenzo; Yongwon Choi
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

Review 6.  Skeletal remodeling in health and disease.

Authors:  Mone Zaidi
Journal:  Nat Med       Date:  2007-07       Impact factor: 53.440

Review 7.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

8.  Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency.

Authors:  Jinhu Xiong; Marilina Piemontese; Jeff D Thostenson; Robert S Weinstein; Stavros C Manolagas; Charles A O'Brien
Journal:  Bone       Date:  2014-06-14       Impact factor: 4.398

9.  Evidence for osteocyte regulation of bone homeostasis through RANKL expression.

Authors:  Tomoki Nakashima; Mikihito Hayashi; Takanobu Fukunaga; Kosaku Kurata; Masatsugu Oh-Hora; Jian Q Feng; Lynda F Bonewald; Tatsuhiko Kodama; Anton Wutz; Erwin F Wagner; Josef M Penninger; Hiroshi Takayanagi
Journal:  Nat Med       Date:  2011-09-11       Impact factor: 53.440

10.  Matrix-embedded cells control osteoclast formation.

Authors:  Jinhu Xiong; Melda Onal; Robert L Jilka; Robert S Weinstein; Stavros C Manolagas; Charles A O'Brien
Journal:  Nat Med       Date:  2011-09-11       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.